Review
. 2017 Oct 17;167(8):565-575. doi: 10.7326/M17-1361. Epub 2017 Oct 10. Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic ReviewAffiliations
AffiliationItem in Clipboard
Review
Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic ReviewKevin Selby et al. Ann Intern Med. 2017.
. 2017 Oct 17;167(8):565-575. doi: 10.7326/M17-1361. Epub 2017 Oct 10. AffiliationItem in Clipboard
AbstractBackground: Fecal immunochemical testing is the most commonly used method for colorectal cancer screening worldwide. However, its effectiveness is frequently undermined by failure to obtain follow-up colonoscopy after positive test results.
Purpose: To evaluate interventions to improve rates of follow-up colonoscopy for adults after a positive result on a fecal test (guaiac or immunochemical).
Data sources: English-language studies from the Cochrane Central Register of Controlled Trials, PubMed, and Embase from database inception through June 2017.
Study selection: Randomized and nonrandomized studies reporting an intervention for colonoscopy follow-up of asymptomatic adults with positive fecal test results.
Data extraction: Two reviewers independently extracted data and ranked study quality; 2 rated overall strength of evidence for each category of study type.
Data synthesis: Twenty-three studies were eligible for analysis, including 7 randomized and 16 nonrandomized studies. Three were at low risk of bias. Eleven studies described patient-level interventions (changes to invitation, provision of results or follow-up appointments, and patient navigators), 5 provider-level interventions (reminders or performance data), and 7 system-level interventions (automated referral, precolonoscopy telephone calls, patient registries, and quality improvement efforts). Moderate evidence supported patient navigators and provider reminders or performance data. Evidence for system-level interventions was low. Seventeen studies reported the proportion of test-positive patients who completed colonoscopy compared with a control population, with absolute differences of -7.4 percentage points (95% CI, -19 to 4.3 percentage points) to 25 percentage points (CI, 14 to 35 percentage points).
Limitation: More than half of studies were at high or very high risk of bias; heterogeneous study designs and characteristics precluded meta-analysis.
Conclusion: Patient navigators and giving providers reminders or performance data may help improve colonoscopy rates of asymptomatic adults with positive fecal blood test results. Current evidence about useful system-level interventions is scant and insufficient.
Primary funding source: National Cancer Institute. (PROSPERO: CRD42016048286).
Conflict of interest statementDisclosures: Dr. Selby reports grants from the National Cancer Institute and the Swiss Cancer Research Foundation and funding from the Swiss National Science Foundation during the conduct of the study. Dr. Levin reports grants from the National Institutes of Health during the conduct of the study. Dr. Doubeni reports being a member of the U.S. Preventive Services Task Force during the conduct of the study and personal fees from UpToDate outside the submitted work. Dr. Jensen reports grants from the National Cancer Institute during the conduct of the study. Dr. Corley reports grants from the National Cancer Institute during the conduct of the study. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M171361 .
FiguresFigure 1.
Flow chart of study selection…
Figure 1.
Flow chart of study selection for interventions to improve follow-up of positive fecal…
Figure 1.Flow chart of study selection for interventions to improve follow-up of positive fecal blood tests for colorectal cancer screening. CENTRAL = Cochrane Central Register of Controlled Trials.
Figure 2.
Overview of included studies of…
Figure 2.
Overview of included studies of interventions to improve follow-up of positive fecal blood…
Figure 2.Overview of included studies of interventions to improve follow-up of positive fecal blood tests for colorectal cancer screening, by intervention level and category. HR = hazard ratio; NA = not applicable; NR = not reported. n/a: not available; UK: United Kingdom; USA: United States of America *Studies with separate reporting of more than one comparison are listed as A, B, C with further details in Table 1 †Risk of bias for individual study according to Agency for Healthcare Research and Quality and GRADE criteria (36,37), details in Appendix B ‖Follow-up interval given only when specifically provided by authors, otherwise marked unspecified #Adjusted absolute change, as reported by study authors
Similar articlesCrider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Crider K, et al. Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Selby K, Senore C, Wong M, May FP, Gupta S, Liang PS. Selby K, et al. J Med Screen. 2021 Mar;28(1):51-53. doi: 10.1177/0969141320904977. Epub 2020 Feb 13. J Med Screen. 2021. PMID: 32054392 Free PMC article.
Medical Advisory Secretariat. Medical Advisory Secretariat. Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1. Ont Health Technol Assess Ser. 2009. PMID: 23074514 Free PMC article.
Lin JS, Piper MA, Perdue LA, Rutter CM, Webber EM, O'Connor E, Smith N, Whitlock EP. Lin JS, et al. JAMA. 2016 Jun 21;315(23):2576-94. doi: 10.1001/jama.2016.3332. JAMA. 2016. PMID: 27305422 Review.
Davis MM, Freeman M, Shannon J, Coronado GD, Stange KC, Guise JM, Wheeler SB, Buckley DI. Davis MM, et al. BMC Cancer. 2018 Jan 6;18(1):40. doi: 10.1186/s12885-017-3813-4. BMC Cancer. 2018. PMID: 29304835 Free PMC article. Review.
Carethers JM, Doubeni CA. Carethers JM, et al. Gastroenterology. 2020 Jan;158(2):354-367. doi: 10.1053/j.gastro.2019.10.029. Epub 2019 Nov 1. Gastroenterology. 2020. PMID: 31682851 Free PMC article. Review.
Coronado GD, Rawlings AM, Petrik AF, Slaughter M, Johnson ES, Hannon PA, Cole A, Vu T, Mummadi RR. Coronado GD, et al. Cancer Epidemiol Biomarkers Prev. 2021 Dec;30(12):2327-2333. doi: 10.1158/1055-9965.EPI-20-1793. Epub 2021 Sep 28. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 34583969 Free PMC article. Clinical Trial.
Hahn EE, Munoz-Plaza CE, Jensen CD, Ghai NR, Pak K, Amundsen BI, Contreras R, Cannizzaro N, Chubak J, Green BB, Skinner CS, Halm EA, Schottinger JE, Levin TR. Hahn EE, et al. J Gen Intern Med. 2024 Dec;39(16):3205-3216. doi: 10.1007/s11606-024-08764-0. Epub 2024 May 21. J Gen Intern Med. 2024. PMID: 38771535
Llovet D, Serenity M, Conn LG, Bravo CA, McCurdy BR, Dubé C, Baxter NN, Paszat L, Rabeneck L, Peters A, Tinmouth J. Llovet D, et al. Am J Gastroenterol. 2018 Dec;113(12):1872-1880. doi: 10.1038/s41395-018-0381-4. Epub 2018 Oct 25. Am J Gastroenterol. 2018. PMID: 30361625 Free PMC article.
Doubeni CA, Selby K, Gupta S. Doubeni CA, et al. Annu Rev Med. 2021 Jan 27;72:383-398. doi: 10.1146/annurev-med-051619-035840. Epub 2020 Nov 18. Annu Rev Med. 2021. PMID: 33208026 Free PMC article. Review.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3